Maitra Souvik, Baidya Dalim K, Bhattacharjee Sulagna, Som Anirban
All India Institute of Medical Sciences, Department of Anaesthesiology & Intensive Care, New Delhi, Índia.
All India Institute of Medical Sciences, Department of Anaesthesiology & Intensive Care, New Delhi, Índia.
Rev Bras Anestesiol. 2017 May-Jun;67(3):294-304. doi: 10.1016/j.bjan.2016.07.005. Epub 2017 Mar 1.
Sternotomy for cardiac surgeries causes significant postoperative pain and when not properly managed may cause significant morbidity. As neuropathic pain is a significant component here, gabapentin and pregabalin may be effective in these patients and may reduce postoperative opioid consumption. The purpose of this systematic review was to find out efficacy of gabapentin and pregabalin in acute postoperative pain after cardiac surgery.
Published prospective human randomized clinical trials, which compared preoperative and/or postoperative gabapentin/pregabalin with placebo or no treatment for postoperative pain management after cardiac surgery has been included in this review.
Four RCTs each for gabapentin and pregabalin have been included in this systematic review. Three gabapentin and two pregabalin studies reported decrease in opioid consumption in cardiac surgical patients while one gabapentin and two pregabalin studies did not. Three RCTs each for gabapentin and pregabalin reported lower pain scores both during activity and rest. The drugs are not associated with any significant complications.
Despite lower pain scores in the postoperative period, there is insufficient evidence to recommend routine use of gabapentin and pregabalin to reduce opioid consumption in the cardiac surgical patients.
心脏手术的胸骨切开术会导致显著的术后疼痛,若处理不当可能会引发严重的并发症。由于神经性疼痛是其中的一个重要因素,加巴喷丁和普瑞巴林可能对这些患者有效,并可能减少术后阿片类药物的用量。本系统评价的目的是探究加巴喷丁和普瑞巴林在心脏手术后急性疼痛中的疗效。
本评价纳入了已发表的前瞻性人体随机临床试验,这些试验比较了术前和/或术后使用加巴喷丁/普瑞巴林与安慰剂或不进行治疗对心脏手术后疼痛管理的效果。
本系统评价纳入了四项关于加巴喷丁和四项关于普瑞巴林的随机对照试验。三项加巴喷丁研究和两项普瑞巴林研究报告称心脏手术患者的阿片类药物用量减少,而一项加巴喷丁研究和两项普瑞巴林研究则未发现此现象。三项加巴喷丁研究和三项普瑞巴林研究均报告称患者在活动和休息时的疼痛评分较低。这些药物未出现任何严重并发症。
尽管术后疼痛评分较低,但尚无足够证据推荐常规使用加巴喷丁和普瑞巴林来减少心脏手术患者的阿片类药物用量。